FDA considers a material being "authorized for investigation as a whole new drug" whether it is the topic of the Investigational New Drug application (IND) that has gone into outcome. Under FDA’s regulations (21 CFR 312.two), Unless of course a clinical investigation meets the constrained requirements in that regulation, an https://auto-accident-legal-help01122.aioblogs.com/86257121/how-much-you-need-to-expect-you-ll-pay-for-a-good-terpenes